XML 28 R17.htm IDEA: XBRL DOCUMENT

Note 10 - Collateralized Securities Transactions

6 Months Ended

Jun. 30, 2024

Notes to Financial Statements

Repurchase Agreements, Resale Agreements, Securities Borrowed, and Securities Loaned Disclosure [Text Block]

10. COLLATERALIZED SECURITIES TRANSACTIONS

Gestation Repo

Gestation repo involves entering into repo and reverse repo transactions where the underlying collateral security represents a pool of newly issued mortgage loans. The borrowers (the reverse repo counterparties) are generally mortgage originators. The lenders (the repo counterparties) are a diverse group of the counterparties comprised of banks, insurance companies, and other financial institutions. The Company self-clears its gestation repo transactions.

Gestation trades can be structured in two ways:

On Balance Sheet: The Company executes a reverse repo with the borrower and a matching repo (with the same collateral and maturity date) with the lender. In this case, the Company is a principal to each trade and is borrowing from one counterparty and lending to another and earning net interest margin. These transactions are referred to by the Company as on balance sheet gestation repo trades.

Agency Repo: Similar to the on balance sheet repo, the Company first executes a reverse repo with the borrower and a matching repo (with the same collateral and maturity date) with the lender. However, in this case, all three parties (the borrower, the lender, and the Company) simultaneously enter into an assignment agreement. The effect of this assignment is to remove the Company as principal to the reverse repo and repo and have the lender and borrower directly face each other in a repo trade. The Company receives a fee for its role in arranging the financing. These transactions are referred to by the Company as agency gestation repo trades.

Bankruptcy of Gestation Repo Counterparty

As of June 30, 2022, the Company had an outstanding reverse repo balance with First Guaranty Mortgage Corporation (“FGMC”) totaling $269,228. Effective June 30, 2022, FGMC filed for bankruptcy. Subsequent to June 30, 2022, the Company issued a default notice to FGMC under the reverse repo. The Company took possession of the collateral and began liquidating it. As of June 30, 2024 and December 31, 2023, the Company had liquidated all of the collateral with the exception of $1,542 and $3,113, respectively, of residential mortgage loans. These loans are carried at fair value and are included in investments-trading in the consolidated balance sheets. During the six months ended June 30, 2024 and 2023, the Company recorded a gain of $15 and a loss of ($1,478), respectively, which are included as a component of net trading revenue and are related to the change in the fair value of the remaining collateral. The remaining loan was liquidated in July 2024.

Other Repo Transactions

In addition to the Company’s gestation repo business, the Company may also enter into reverse repos to acquire securities to cover short positions or as an investment. Additionally, the Company may enter into repos to finance the Company’s securities positions held in inventory. These repo and reverse repo agreements are generally cleared on a bilateral or triparty basis; no clearing broker is involved.

Repo Information

As of June 30, 2024 and December 31, 2023, the Company held reverse repos of $541,955 and $408,408, respectively, and the fair value of collateral received under reverse repos was $548,928 and $415,057, respectively.

As of June 30, 2024 and December 31, 2023, the Company held repos of $541,734 and $408,203, respectively, and the fair value of securities and cash pledged as collateral under repos was $548,928 and $415,057, respectively. These amounts include collateral for reverse repos that were re-pledged as collateral for repos.

Concentration

In the gestation repo business, the demand for borrowed funds is generated by the reverse repo counterparty and the supply of funds is provided by the repo counterparty.

The gestation repo business has been and continues to be concentrated with respect to reverse repurchase counterparties. The Company conducts this business with a limited number of reverse repo counterparties. As of June 30, 2024 and December 31, 2023, the Company’s gestation reverse repos shown in the tables below represented balances from 7 and 7 counterparties, respectively. The Company also has a limited number of repo counterparties in the gestation repo business. However, this is primarily a function of the limited number of reverse repo agreement counterparties with whom the Company conducts this business rather than a reflection of a limited supply of funds. Therefore, the Company considers the gestation repo business to be concentrated on the demand side.

The total net revenue earned by the Company on its gestation repo business (net interest margin and fee revenue) was $3,693 and $7,149 for the three and six months ended June 30, 2024, respectively. The total net revenue earned by the Company on its gestation repo business was $4,015 and $8,396 for the three and six months ended June 30, 2023, respectively.

Detail

ASC 210 provides the option to present reverse repo and repo on a net basis if certain netting conditions are met. The Company presents all repo and reverse repo transactions, as well as counterparty cash collateral (see note 13), on a gross basis even if the underlying netting conditions are met. The amounts in the table below are presented on a gross basis.

The following tables summarize the remaining contractual maturity of the gross obligations under repos accounted for as secured borrowings segregated by the underlying collateral pledged as of each date shown. All amounts as well as counterparty cash collateral (see note 13) are subject to master netting arrangements.

SECURED BORROWINGS

(Dollars in Thousands)

June 30, 2024

		Repurchase Agreements
		Remaining Contractual Maturity of the Agreements
		Overnight and				Up to				30 - 90				Greater than
Collateral Type:		Continuous				30 days				days				90 days				Total
MBS (gestation repo)		$	125,503			$	416,231			$	-			$	-			$	541,734
		$	125,503			$	416,231			$	-			$	-			$	541,734

		Reverse Repurchase Agreements
		Remaining Contractual Maturity of the Agreements
		Overnight and				Up to				30 - 90				Greater than
Collateral Type:		Continuous				30 days				days				90 days				Total
MBS (gestation repo)		$	125,582			$	416,373			$	-			$	-			$	541,955
		$	125,582			$	416,373			$	-			$	-			$	541,955

The weighted average interest rate of the repurchase agreements outstanding as of June 30, 2024 was 6.08%. The weighted average interest rate of the reverse repurchase agreements outstanding as of June 30, 2024 was 6.68%.

SECURED BORROWINGS

(Dollars in Thousands)

December 31, 2023

		Repurchase Agreements
		Remaining Contractual Maturity of the Agreements
		Overnight and				Up to				30 - 90				Greater than
Collateral Type:		Continuous				30 days				days				90 days				Total
MBS (gestation repo)		$	-			$	408,203			$	-			$	-			$	408,203
		$	-			$	408,203			$	-			$	-			$	408,203

		Reverse Repurchase Agreements
		Remaining Contractual Maturity of the Agreements
		Overnight and				Up to				30 - 90				Greater than
Collateral Type:		Continuous				30 days				days				90 days				Total
MBS (gestation repo)		$	-			$	408,408			$	-			$	-			$	408,408
		$	-			$	408,408			$	-			$	-			$	408,408

The weighted average interest rate of the repurchase agreements outstanding as of December 31, 2023 was 6.10%. The weighted average interest rate of the reverse repurchase agreements outstanding as of December 31, 2023 was 6.87%.